Sialic acid and sialidase activity in acute stroke

Area of Science:

• Biochemistry
• Neurology
• Hematology

Background:

• Stroke is a complex neurological condition involving disrupted cerebral blood flow.
• Erythrocytes, rich in sialic acid, may offer insights into stroke-related biochemical changes.
• Sialic acid and sialidase activity are implicated in various physiological and pathological processes.

Purpose of the Study:

• To investigate the relationship between erythrocyte membrane, plasma, and sialic acid content in stroke patients.
• To evaluate the impact of sialic acid content and sialidase activity on stroke severity.
• To identify potential biochemical markers for ischemic stroke.

Main Methods:

• Compared sialic acid content and sialidase activity in 54 first-stroke patients and 53 healthy controls.
• Measured total bound sialic acid in erythrocytes and plasma.
• Assessed neurological deficit severity using the National Institute of Health Stroke Scale (NIHSS).

Main Results:

• Total bound sialic acid was significantly decreased in erythrocytes of stroke patients.
• Elevated sialidase activity showed a significant correlation with higher NIHSS scores (stroke severity).
• Stroke patients exhibited lower erythrocyte sialic acid and higher plasma sialic acid levels alongside increased sialidase activity.

Conclusions:

• Low erythrocyte sialic acid, high plasma sialic acid, and elevated sialidase activity may serve as markers for ischemic stroke.
• These biochemical alterations could play a role in the development and progression of cerebral ischemic damage.
• Further research is warranted to elucidate the precise mechanisms linking these findings to stroke pathophysiology.